Samantha Womack: ‘Following my instincts saved my life'
Although she felt fit and healthy, actress Samantha Womack had a gut feeling that something was wrong with her.
So she had a private ultrasound scan of her breasts which found a 4cm cancerous tumour.
Advertisement
Three years after the shock discovery, Womack is clear of cancer after having the tumour removed, plus chemotherapy and radiotherapy.
View this post on Instagram
A post shared by Sam Womack (@samzjanus)
But she's urging other women to follow their instincts if they're concerned about their health in any way, and stresses: 'If anything feels wrong, you just have to get as much information as you can and get it checked out, because it literally saved my life
'I wasn't quite 50, and I didn't have a lump – I didn't have any symptoms. I was generally healthy, and for some reason I just had an instinct that maybe something wasn't right. So in the middle of two shows, I went to get an ultrasound, and saw a black shadow there. Immediately, when I saw it was an irregular shape, I thought 'I know what that is'.'
Womack, who played Ronnie Mitchell in EastEnders until 2017, was diagnosed with an aggressive grade three invasive ductal carcinoma in her right breast. The cancer had already started to travel to her lymph nodes, and she had five nodes removed.
'The journey then became very much about listening to my instincts and responding to what my body needed, and getting as much information as I could about the cancer,' she explains, 'because what if I hadn't listened to my intuition, my other voice? My diagnosis and treatment would have been very different.'
Advertisement
(Alamy/PA)
Now Womack, 52, who divides her time between the UK and her home in the mountains near Valencia in Spain, is championing a campaign to get women who are undergoing breast cancer tests to ask whether their breast tissue is dense or not.
The Keep Abreast of your Breast Density campaign by private cancer care provider GenesisCare explains that although mammograms are an excellent breast cancer screening tool, it's harder to spot tumours in mammograms of dense breast tissue, which is a measurement of how much fibroglandular tissue there is in a woman's breast versus fatty tissue.
GenesisCare says dense breast tissue is found in around half of women aged over 40, and women with extremely dense breasts are six times more likely to get breast cancer than those with fatty breasts. However, women in the UK are not currently informed about their breast density following a mammogram, and no further additional imaging is offered for women with dense breasts.
Womack says she still doesn't know if she has dense breasts herself, pointing out: 'During the whole process, I hadn't understood about dense breasts – no-one had mentioned the term to me. But then when I understood, I learned that the denser your breasts, an all-clear with a mammogram doesn't necessarily mean you're clear. If you've got fatty breasts, tumours are easy to see, but as they become more fibrous, it's more difficult.'
Advertisement
Womack is urging women to ask doctors whether they have dense breasts or not, and if they have, then decide whether they want any further tests after a mammogram.
'We still have this mentality of doctors know best and you shouldn't really push the health service because they're doing all they can,' she says. 'A lot of the time that's right. But if you feel like there's anything wrong, and you're not quite 50, or you're over 50 and you've had a mammogram and you've been given the all-clear, but something still doesn't feel right, the information about whether you have dense breasts can massively change your treatment.
'I just realised how ill-informed we are, and how nervous sometimes we are to ask questions. It's about taking control of your own body. If anything feels wrong, if you've got a lump that's persistent and won't go away, if you've had a mammogram and it doesn't feel right, or something is telling you that you should go back, you should listen to that.
'And you absolutely should ask what density your breasts are, because it really makes a difference in terms of finding tumours.'
Advertisement
Womack now has check-ups every six months, and says she's trying to lead a healthier lifestyle, enjoying walking her six rescue dogs in the mountains around Valencia, where she lives part-time with her partner, actor Oliver Farnworth who plays John Sugden in Emmerdale.
View this post on Instagram
A post shared by Sam Womack (@samzjanus)
'I've just chosen to be around nature – it's a calmer lifestyle. It's quieter,' she says happily.
'That's not just because of the cancer – I just enjoy it. I walk the dogs every day, and I try to make good choices about my body. I'm just listening to my body a lot more, I think, rather than being panicked about what I eat and how much I sleep. You can be neurotic about those kind of things. I'm sensible.
'But the main thing is if anything's wrong, I follow my instinct and I get it checked out. And I really encourage all women to do the same and not be afraid to ask questions.'
But what do independent experts have to say about dense breasts and cancer screening?
Advertisement
View this post on Instagram
A post shared by Breast Cancer Now (@breastcancernow)
Sally Kum, associate director of nursing and health information at the
Breast Cancer Now
charity, confirms: 'Having dense breasts both increases the risk of breast cancer and makes it harder to identify potential cancers on a routine mammogram.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Guardian
20 minutes ago
- The Guardian
I wish I had known more about alcohol when I started drinking
You're going to want to sit down with a big glass of water for this one, because I'm afraid I have some bad news. Here we go: alcohol is not terribly good for you. Shocker, right? You've probably never heard anything like this before in your life. No doubt, you've been choking down a glass of pinot with dinner whenever you can stomach it because you thought it was good for your cholesterol. Instead, it is elevating your risk of cancer. If public health experts have their way, the fact that alcohol is carcinogenic is going to be very hard for British drinkers to ignore. Dozens of medical and health organisations recently wrote to Keir Starmer urging the prime minister to force companies to include 'bold and unambiguous' labels on booze bottles, warning that alcohol causes cancer. Currently only about a quarter of countries require any sort of health warnings on alcohol and these are generally vague and in small print. However, there are growing calls for more aggressive messaging. In 2016, South Korea mandated a number of warning labels for alcohol, including one that specified links to liver cancer. (Manufacturers can choose which label to use, and don't need to use the one linked to cancer.) In 2023, meanwhile, Ireland signed a law (which comes into effect next year) that made it the first country to mandate warning labels specifying a direct link between alcohol and fatal cancers. The US has been mulling a similar move: Vivek Murthy, the US surgeon general under Joe Biden, called for alcohol warnings in a report published in January. Might Donald Trump's current nominee for surgeon general, Casey Means (a wellness influencer who doesn't have an active medical licence), carry out these recommendations? Possibly. She's been outspoken about the harms of alcohol, albeit in an idiosyncratic way. 'When I'm off my healthy habits, and drinking regularly, it feels like the mystical realm is harder for me to access,' Means wrote in an old blog post about her dry January efforts. 'I so eagerly want to thin that veil between me and the spiritual dimension,' she added, 'so for me, I think alcohol needs to take a lesser role in my life.' Warning: alcohol may give you cancer and also throw your chakras out of balance. While it may be a little paternalistic, I think putting more explicit warning labels on alcohol is a sensible move. Yes, we all know that alcohol is bad for us, but knowing something in the abstract is very different from being reminded about specific risks at the point of consumption. And while few people labour under the delusion that alcohol is a health product, there is evidence that a lot of people don't understand the risks involved with even relatively small amounts. There are certainly a lot of things I wish I had known about alcohol early on in my drinking life, including the fact that you might not necessarily have any symptoms of liver damage until you are in serious trouble. I am not fully retired from drinking now but, like a lot of people, I'm 'sober curious'. All that said, I am sceptical about the efficacy of the 'No amount of alcohol is safe for you' messaging put out by the World Health Organization in 2023. Messaging that absolutist can be easy to ignore or can be used to justify binge-drinking. After all, if no amount of alcohol is good for you, then what's the point of stopping at one? Some experts have also argued that the 'Every drop is evil' messaging lacks nuance and cherrypicks data. 'The data do not justify sweeping statements about the effects of moderate alcohol consumption on human health,' two researchers from the Harvard TH Chan School of Public Health said in an opinion piece last year. In 2018, David Spiegelhalter, a British expert in the public understanding of risk, similarly noted that the public should be given more detail on the degree to which low-level alcohol use actually increases your risk of cancer. He added: 'Claiming there is no 'safe' level [for drinking] does not seem an argument for abstention. There is no safe level of driving, but government do not recommend that people avoid driving. Come to think of it, there is no safe level of living, but nobody would recommend abstention.' He's quite right about that last bit, I'm afraid: recent research shows that life comes with a 100% risk of death. A sobering statistic if ever there was one. Arwa Mahdawi is a Guardian columnist Do you have an opinion on the issues raised in this article? If you would like to submit a response of up to 300 words by email to be considered for publication in our letters section, please click here
Times
20 minutes ago
- Times
Weight-loss drugs shrink supermarket sales
The growing popularity of weight-loss drugs threatens to shrink the bottom line at British supermarkets. Total grocery sales volumes fell in the past four weeks, for the first time this year, which, according to experts at Kantar, could partly be due to changing health priorities from the use of 'skinny jabs'. Fraser McKevitt, head of retail and consumer insight at Kantar, said of the 0.4 per cent year-on-year drop: 'Supermarkets and grocery brands are entering new territory as weight-loss drugs become more popular, with four in a hundred households in Britain now including at least one GLP-1 user. • Business live: the latest news on companies, markets and economics 'That's almost twice as many as last year so, while it's still pretty low, it's definitely a trend that the industry should keep an eye on as these drugs have the potential to steer choices at the till. Four in five of the users we surveyed say they plan to eat fewer chocolates and crisps, and nearly three quarters intend to cut back on biscuits.' The craze for the breakthrough weight-loss jabs developed by Novo Nordisk of Denmark and Eli Lilly of the United States has led analysts to estimate that the weight-loss drugs market could be worth up to $150 billion by the end of the decade. It has also led to debates about the knock-on impact on other industries, such as food and alcohol. Academics at Cornell University, New York, examined in a paper in December how consumers are modifying their food demand after adopting the appetite-suppressing jabs. Using survey responses on medication adoption and timing linked to transaction data from a representative US household panel, the researchers found that households with at least one GLP-1 user reduced grocery spending by 5.5 per cent within six months of adoption. Higher-income households cut spending by 8.6 per cent. The paper, titled The No-Hunger Games: How GLP-1 Medication Adoption is Changing Consumer Food Demand, found that the reductions were driven by large decreases in purchases of 'calorie-dense, processed items'. 'Our findings highlight the potential for GLP-1 medications to significantly change food demand, a trend with increasingly important implications for the food industry as GLP-1 adoption continues to grow,' the researchers said. The veteran investor Terry Smith previously offloaded his fund's stake in Diageo, the owner of Guinness and Johnnie Walker whisky, over concerns that the development of anti-obesity drugs could reduce demand for alcohol. Jamie Ross, a portfolio manager at Henderson EuroTrust, said last year: 'Will people taking weight-loss drugs drink less alcohol? Will they avoid frozen food? Will sugar consumption be hit? These are all questions that inform investment decisions today but the answers will not be visible for several years to come.' In the UK more than 1.5 million people are taking weight-loss jabs and most buy them online from pharmacies, according to recent industry figures. Sales have more than doubled in the past six months, data from the life science analytics company Iqvia showed, and about 1,527,000 prescriptions were supplied in March this year.
The Guardian
29 minutes ago
- The Guardian
Tobacco exposure killed more than 7m people in 2023, study finds
Exposure to tobacco killed more than 7 million people worldwide in 2023, according to estimates. It remains the leading risk factor for deaths in men, among whom there were 5.59m deaths, and ranks seventh for women, among whom there were 1.77m deaths. While the UK has seen a 45% decline in deaths attributed to tobacco since 1990 – including smoking, chewing tobacco and secondhand smoke – the global rate has risen by 24.4%. The analysis, from the Institute for Health Metrics and Evaluation (IHME) at the University of Washington, is based on data from the Global Burden of Disease study and was presented at the World Conference on Tobacco Control in Dublin on Monday. Some countries have experienced dramatic rises, the researchers said, with the highest jump in Egypt, where deaths in 2023 were 124.3% higher than in 1990. Brooks Morgan, a researcher at the IHME, said: 'Tobacco exposure is one of the most significant risk factors identified in the Global Burden of Disease study 2023, contributing to approximately one in eight deaths worldwide. 'While some countries are seeing encouraging declines in tobacco-related deaths, others are heading in the opposite direction. These trends highlight the urgent need for accelerated implementation and stronger enforcement of strategies proven to reduce tobacco use.' In separate research, a team from the Institute of Clinical and Health Effectiveness (IECS) in Argentina looked at the impact of tobacco use in Bolivia, Honduras, Nigeria, Paraguay and Uruguay. They calculated tobacco had caused more than 41,000 deaths in the five low- and middle-income countries, and cost nearly $4.3bn (£3.4bn) in medical expenses, lost productivity and informal caregiving. Natalia Espínola, a coordinator of health economics at the IECS, said the total was equivalent to about 1% of the countries' combined GDP. Cassandra Kelly-Cirino, the executive director of the International Union Against Tuberculosis and Lung Disease, said: 'The research showcased today at the World Conference on Tobacco Control is a powerful reminder that tobacco remains one of the most devastating public health threats of our time. There is no such thing as a healthy tobacco product, and reduced risk all too often just means increased profit for industry. We must take a zero-tolerance approach.' A report published by the World Health Organization on Monday urged countries to go further in efforts to tackle tobacco and newer nicotine products such as vapes, including by raising taxes and requiring graphic warnings on packaging. Dr Tedros Adhanom Ghebreyesus, the WHO director general, told the conference that progress in tobacco control was fragile. He said: 'Despite the rise in regulation, the tobacco industry continues to evolve, pushing new products, targeting youth, and working to erode our gains.' Higher taxes on tobacco could 'be used for the gaps' in health funding caused by drops in overseas aid in many countries, he suggested. In another study presented at the conference, researchers from Fudan University in China showed that an AI mobile phone tool designed to help smokers quit using tailored messages and games could double their chances of success. In a trial involving 272 smokers, 17.6% of those using the tool quit, against 7.4% of those in a control group.
